Skip to main content

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) — Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.

The affected lots were distributed nationwide in the United States through retailers and online from 12/14/2022 through 06/04/2025.

The table below identifies the UPC, lot numbers, and expiration dates of the Little Remedies® Honey Cough Syrup impacted by this recall.

Item UPCLot #Exp. Date
7-56184-10737-9003911/2025
054501/2026
064002/2026
045005/2026
119812/2026

Little Remedies® Honey Cough Syrup is packaged in a 4 FL OZ (118 mL) amber bottle and is sold in an outer carton with the Lot Code appearing both on the bottle label and on the bottom of the carton (images below).

This recall does not include any other Little Remedies® products.

Bottle Label:

Bottle Label:

Carton:

Carton:

No serious adverse events have been reported to date.

All lots of Little Remedies® Honey Cough 4 FL OZ (118 mL) still within expiry are being included in the scope of the recall.

Consumers who have the recalled Product should stop using it immediately and should contact their physician or healthcare provider if they have experienced any problems that may be related to the use of this Product. The company will also offer reimbursement for consumers who have purchased Products from the recalled lots.

Consumers with refund requests or questions regarding this recall can contact Medtech via e-mail at medicalaffairs@prestigebrands.com, through its website at https://www.prestigebrands.com/contact, or by phone at (800) 754-8853 on Monday – Friday 8:30-5:30 eastern time.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/ca32fb6c-5efc-4785-bf61-239d42d91bfb

https://www.globenewswire.com/NewsRoom/AttachmentNg/fca77e04-87d0-45ef-b10e-7b13ae6e4adc

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.